Dark
Light
System
Security
Spring Bank Pharmaceuticals In
Spring Bank Pharmaceuticals In. Institutional holdings reported to the SEC.

Institutional Holders (2017Q1)
Portfolio Summary: 19 Institutional holders with a total value of $12,275,000.
#
Manager Name
Shares
Value ($)
%
Options
Notes
1 TIEDEMANN ADVISORS, LLC 310,490 2,763,000 22.51%
2 PARSONS CAPITAL MANAGEMENT INC/RI 233,443 2,078,000 16.93%
3 BAKER BROS. ADVISORS LP 219,298 1,952,000 15.90%
4 Alyeska Investment Group, L.P. 200,000 1,780,000 14.50% Call
5 Alyeska Investment Group, L.P. 152,361 1,356,000 11.05%
6 MILLENNIUM MANAGEMENT LLC 65,015 579,000 4.72%
7 Private Capital Advisors, Inc. 37,500 334,000 2.72%
8 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 28,300 252,000 2.05%
9 KING LUTHER CAPITAL MANAGEMENT CORP 31,180 239,000 1.95%
10 MORSE ASSET MANAGEMENT, INC 24,800 223,000 1.82%
11 GOLDMAN SACHS GROUP INC 20,249 180,000 1.47%
12 LEE FINANCIAL CORP 18,750 167,000 1.36%
13 Verity & Verity, LLC 17,785 158,000 1.29%
14 Wilmington Savings Fund Society, FSB 14,000 125,000 1.02%
15 MORGAN STANLEY 6,250 56,000 0.46%
16 UBS Group AG 2,328 21,000 0.17%
17 BESSEMER GROUP INC 1,250 11,000 0.09%
18 BlackRock Finance, Inc. 163 1,000 0.01%
19 DEUTSCHE BANK AG\ 100 0 0.00%

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.